Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last CNY17.44 CNY
Change Today +0.04 / 0.23%
Volume 4.7M
As of 3:05 AM 09/30/15 All times are local (Market data is delayed by at least 15 minutes).

shanghai pharmaceuticals-a (601607) Snapshot

Previous Close
Day High
Day Low
52 Week High
05/18/15 - CNY32.10
52 Week Low
10/27/14 - CNY13.87
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for SHANGHAI PHARMACEUTICALS-A (601607)

Related News

No related news articles were found.

shanghai pharmaceuticals-a (601607) Related Businessweek News

No Related Businessweek News Found

shanghai pharmaceuticals-a (601607) Details

Shanghai Pharmaceuticals Holding Co., Ltd., together with its subsidiaries, researches and develops, manufactures, distributes, and retails pharmaceutical and healthcare products in the People’s Republic of China. The company operates through Production, Distribution, Retail, and Others segments. It offers products ranging from chemical and bio-pharms, modern Chinese medicine, healthcare products, medical devices, etc. in various therapeutic areas, including cardiovascular, systemic anti-infections, digestive system and immune-metabolism, neuropsychiatric, antineoplastic, musculo-skeletal, respiratory, and genito-urinary systems, as well as offers sex hormones and products for blood and blood-forming organs. The company offers its products in various dosage forms, such as tablets, capsules, powder, mini-volume injections, eye-drops, inhalants, coagulants, etc. It is also involved in the distribution of vaccines and high-end consumables; wholesale of active pharmaceutical ingredients; and provision of distribution, warehousing, logistics, and other value-added pharmaceutical supply chain solutions and related services to pharmaceutical manufacturers and dispensers, such as hospitals, distributors, and retail pharmacies. In addition, the company operates a network of retail pharmacy stores; manages assets; manufactures and trades medicines and medical equipment; and rents properties. It has approximately 1,895 chain retail pharmacies under its brand family, including 1,193 directly operated pharmacies. The company was incorporated in 1994 and is headquartered in Shanghai, the People's Republic of China. Shanghai Pharmaceuticals Holding Co., Ltd. is a subsidiary of Shanghai Pharmaceutical (Group) Co., Ltd.

38,942 Employees
Last Reported Date: 08/26/15
Founded in 1994

shanghai pharmaceuticals-a (601607) Top Compensated Officers

President and Executive Director
Total Annual Compensation: CNY1.6M
Chairman, Convener of Strategy Committee and ...
Total Annual Compensation: --
Executive Director
Total Annual Compensation: --
Vice President
Total Annual Compensation: --
Compensation as of Fiscal Year 2014.

shanghai pharmaceuticals-a (601607) Key Developments

Shanghai Pharmaceuticals Eye Swisse Wellness

Chinese in the running for Swisse Wellness Pty Ltd. captured the attention of Shanghai Pharmaceuticals Holding Co., Ltd. (SHSE:601607), a Chinese drug manufacturer that has been waved through to the second round of the $1 billion-plus Goldman Sachs-run sales process. A handful of parties have progressed in the contest, with KKR & Co. L.P. (NYSE:KKR) believed to be on the short list of possible buyers.

Shanghai Pharmaceuticals Holding Co., Ltd. Announces Unaudited Consolidated Earnings Results for the Six Months Ended June 30, 2015

Shanghai Pharmaceuticals Holding Co., Ltd. announced unaudited consolidated earnings results for the six months ended June 30, 2015. For the period, the company reported revenue of RMB 50,950,076,000 compared to RMB 44,013,016,000 a year ago. operating profit was RMB 1,976,284,000 compared to RMB 1,741,970,000 a year ago. profit before income tax was RMB 2,124,660,000 compared to RMB 1,917,104,000 a year ago. profit attributable to owners of the company was RMB 1,534,018,000 or RMB 0.57 per basic and diluted share compared to RMB 1,318,004,000 or RMB 0.49 per basic and diluted share a year ago. Net cash generated from operating activities was RMB 110,636,000 compared to net cash used in operating activities of RMB 74,878,000 a year ago. Purchases of property, plant and equipment (PP&E) and investment properties were RMB 669,805,000 compared to RMB 394,563,000 a year ago. Purchases of treasury bills were RMB 1,000,000,000 compared to RMB 300,000,000 a year ago. Purchases of land use rights and intangible assets were RMB 20,389,000 compared to RMB 6,903,000 a year ago.

Shanghai Pharmaceuticals Holding Co., Ltd. to Report First Half, 2015 Results on Aug 27, 2015

Shanghai Pharmaceuticals Holding Co., Ltd. announced that they will report first half, 2015 results on Aug 27, 2015


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
601607:CH CNY17.44 CNY +0.04

601607 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Huadong Medicine Co Ltd CNY69.85 CNY +1.14
Jointown Pharmaceutical Group Co Ltd CNY15.97 CNY -0.07
Nanjing Pharmaceutical Co Ltd CNY7.69 CNY -0.06
Wanjia Group Holdings Ltd $0.62 HKD +0.04
View Industry Companies

Industry Analysis


Industry Average

Valuation 601607 Industry Range
Price/Earnings 16.3x
Price/Sales 0.5x
Price/Book 1.6x
Price/Cash Flow 11.7x
TEV/Sales 0.1x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact SHANGHAI PHARMACEUTICALS-A, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at